Market Currents
Mylan's (MYL) credit rating is upgraded by both Moody’s and S&P, with the...
-
Wednesday, November 21, 2012, 8:12 AM ETMylan's (MYL) credit rating is upgraded by both Moody’s and S&P, with the drugmaker’s rating now out of junk territory. Moody’s upgraded MYL by two notches to Baa3, one level above junk, while S&P lifted its rating by one notch to BBB-, also one notch above junk. The upgrades follow MYL’s moves to improve operating performance and free cash flow. Shares +0.7% premarket.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
